Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
An HLA-I signature favouring KIR-educated Natural Killer cells mediates immune control of HIV in children and contrasts with the HLA-B-restricted CD8+ T-cell-mediated immune control in adults.
Lack of Effectiveness of Repurposed Drugs for COVID-19 Treatment.
Determinants of HIV-1 Late Presentation in Patients Followed in Europe.
Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients.
Cancer immunotherapy in special challenging populations: recommendations of the Advisory Committee of Spanish Melanoma Group (GEM).
Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodies.
Ultrasound-Based Assessment of Preperitoneal Fat as a Surrogate Marker of Cardiovascular Risk: Comparative Study Between People Living With HIV and Controls.
Stable neutralizing antibody levels 6 months after mild and severe COVID-19 episodes
Diversity and Evolution of HIV and HCV.
Robust HIV-specific CD4+ and CD8+ T-cell responses distinguish the rare phenotype of elite control in adolescents living with HIV from viraemic non-progressors.